H.L. Dickison
H.L. Dickison publishes mostly in Pharmacology, Organic Chemistry and Molecular Biology, on topics such as Pharmacological Receptor Mechanisms and Effects, Microfluidic and Capillary Electrophoresis Applications and Nanoparticle-Based Drug Delivery.
- World rank
- #2,636,535 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #184,411 of 367,258
- Works
- 16
- Citations
- 262
- Citations per work
- 16.4
What does H.L. Dickison research?
H.L. Dickison's work is mostly in Chemistry (18%), Medicine (13%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else848.9%
- Physical Sciences528.9%
- Chemistry317.8%
- Engineering16.7%
- Materials Science14.4%
- Health Sciences213.3%
- Medicine213.3%
- Life Sciences18.9%
- 1Pharmacology13% of their works
- 2Organic Chemistry11% of their works
- 3Molecular Biology9% of their works
- 4Physical and Theoretical Chemistry7% of their works
- 5Biomedical Engineering7% of their works
- 6Biomaterials4% of their works
Research topics
- Pharmacological Receptor Mechanisms and Effects
- Microfluidic and Capillary Electrophoresis Applications
- Nanoparticle-Based Drug Delivery
- Anesthesia and Sedative Agents
- Pharmacological Effects and Toxicity Studies
- Microbial Natural Products and Biosynthesis
- Antibiotics Pharmacokinetics and Efficacy
- Lichen and fungal ecology
Which keywords describe H.L. Dickison's research?
The keywords of their largest research topics: Cancer Therapy, Secondary Metabolites, Anesthesia, Antibiotic Pharmacokinetics, Antiepileptic Drugs, Chaperone, Critically Ill Patients and Drug Delivery.
- Symbiosis
- Sigma-1 Receptor
- Prenatal Exposure
- Natural Products
- Lab-on-a-Chip
- Drug Delivery
- Chaperone
- Antibiotic Pharmacokinetics
- Secondary Metabolites
- Cancer Therapy
- Anesthesia
- Antiepileptic Drugs
- Critically Ill Patients
- Drug Discovery
- Nanocarriers
- Poly(dimethylsiloxane)
- Sedation
- Lichen
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cancer Therapy42 topics
- Secondary Metabolites32 topics
- Anesthesia21 topic
- Antibiotic Pharmacokinetics21 topic
- Antiepileptic Drugs21 topic
- Chaperone21 topic
- Critically Ill Patients21 topic
- Drug Delivery21 topic
- Drug Discovery21 topic
- Lab-on-a-Chip21 topic
- Nanocarriers21 topic
- Natural Products21 topic
- Poly(dimethylsiloxane)21 topic
- Prenatal Exposure21 topic
- Sedation21 topic
- Sigma-1 Receptor21 topic
- Lichen11 topic
- Symbiosis11 topic
Where does H.L. Dickison work?
H.L. Dickison's main affiliation in the publication record is Bristol Laboratories (United Kingdom), United Kingdom.
How many publications and citations does H.L. Dickison have?
OpenAlex counts 16 works and 262 citations for H.L. Dickison, an h-index of 9, ranking #2,636,535 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about H.L. Dickison. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.